National Institute for Occupational Safety and Health, Safety and Occupational Health Study Section, 7114 [05-2568]

Download as PDF 7114 Federal Register / Vol. 70, No. 27 / Thursday, February 10, 2005 / Notices (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Occupational Exposure Risk on Reproduction/Development, Request for Applications (RFA) OH–05–003. Times and Dates: 8 a.m.–8:30 a.m., March 23, 2005 (Open). 8:30 a.m.–5 p.m., March 23, 2005 (Closed). Place: Embassy Suites Hotels, 1900 Diagonal Road, Alexandria, VA 23114 telephone 703–684–5900. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Request for Applications OH–05– 003. Contact Person for More Information: Bernadine Kuchinski, Ph.D. Scientific Review Administrator, National Institute for Occupational Safety and Health, CDC, 4676 Columbia Parkway, MS C7, Cincinnati, OH 45226, Telephone 513–533–8511. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 3, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 05–2571 Filed 2–9–05; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting. Name: Healthcare Infection Control Practices Advisory Committee. Times and Dates: 8:30 a.m.–5 p.m., February 28, 2005. 8:30 a.m.–4 p.m., March 1, 2005. Place: Westin Buckhead, 3391 Peachtree Road, NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with providing advice and guidance to the 16:20 Feb 09, 2005 Dated: February 4, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–2569 Filed 2–9–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate jul<14>2003 Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Infectious Diseases (NCID), regarding (1) the practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: Agenda items will include influenza pandemic preparedness for healthcare facilities; proposed recommendations for prioritization of influenza vaccine; draft recommendations on tuberculosis infection control precautions for healthcare facilities; infection control issues in ambulatory care settings; strategies for surveillance of healthcare-associated infections and healthcare-associated adverse events; and updates on CDC activities of interest to the committee. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Harriett Lynch, Committee Management Specialist, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, 1600 Clifton Road, NE., M/S A–07, Atlanta, Georgia 30333, telephone 404/498–1182. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Jkt 205001 National Institute for Occupational Safety and Health, Safety and Occupational Health Study Section In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92–463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting. Name: Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH). Times and Dates: 8 a.m.–5 p.m., February 22, 2005. 8 a.m.–5 p.m., February 23, 2005. Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia, 22314, telephone 703–684–5900, fax 703–684–1403. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 Status: Open 8 a.m.–8:15 a.m., February 22, 2005. Closed 8:15 a.m.–5 p.m., February 22, 2005. Closed 8 a.m.–5 p.m., February 23, 2005. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters To Be Discussed: The meeting will convene in open session from 8–8:15 a.m. on February 22, 2005, to address matters related to the conduct of Study Section business. The remainder of the meeting will proceed in closed session. The purpose of the closed sessions is for the study section to consider safety and occupational health-related grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Pub. L. 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, Ph.D., NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, telephone 404–498–2511, fax 404–498–2569. Due to programmatic issues that had to be resolved, the Federal Register notice is being published less than fifteen days before the date of the meeting. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 4, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–2568 Filed 2–9–05; 8:45 am] BILLING CODE 4163–19–P E:\FR\FM\10FEN1.SGM 10FEN1

Agencies

[Federal Register Volume 70, Number 27 (Thursday, February 10, 2005)]
[Notices]
[Page 7114]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2568]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Institute for Occupational Safety and Health, Safety and 
Occupational Health Study Section

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Public Law 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Safety and Occupational Health Study Section (SOHSS), 
National Institute for Occupational Safety and Health (NIOSH).
    Times and Dates: 8 a.m.-5 p.m., February 22, 2005. 8 a.m.-5 
p.m., February 23, 2005.
    Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, 
Virginia, 22314, telephone 703-684-5900, fax 703-684-1403.
    Status: Open 8 a.m.-8:15 a.m., February 22, 2005. Closed 8:15 
a.m.-5 p.m., February 22, 2005. Closed 8 a.m.-5 p.m., February 23, 
2005.
    Purpose: The Safety and Occupational Health Study Section will 
review, discuss, and evaluate grant application(s) received in 
response to the Institute's standard grants review and funding 
cycles pertaining to research issues in occupational safety and 
health, and allied areas.
    It is the intent of NIOSH to support broad-based research 
endeavors in keeping with the Institute's program goals. This will 
lead to improved understanding and appreciation for the magnitude of 
the aggregate health burden associated with occupational injuries 
and illnesses, as well as to support more focused research projects, 
which will lead to improvements in the delivery of occupational 
safety and health services, and the prevention of work-related 
injury and illness. It is anticipated that research funded will 
promote these program goals.
    Matters To Be Discussed: The meeting will convene in open 
session from 8-8:15 a.m. on February 22, 2005, to address matters 
related to the conduct of Study Section business. The remainder of 
the meeting will proceed in closed session. The purpose of the 
closed sessions is for the study section to consider safety and 
occupational health-related grant applications. These portions of 
the meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and 
Services Office, Centers for Disease Control and Prevention, 
pursuant to Section 10(d) Pub. L. 92-463.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Price Connor, Ph.D., NIOSH 
Health Scientist, 1600 Clifton Road, NE., Mailstop E-20, Atlanta, 
Georgia 30333, telephone 404-498-2511, fax 404-498-2569.
    Due to programmatic issues that had to be resolved, the Federal 
Register notice is being published less than fifteen days before the 
date of the meeting.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 4, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-2568 Filed 2-9-05; 8:45 am]
BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.